SERPINA5 Antibody

中文名稱：

SERPINA5兔多克隆抗體
貨號：

CSB-PA021061LA01HU
規(guī)格：

￥440
圖片：
Western Blot
Positive WB detected in: Rat liver tissue, Mouse liver tissue
All lanes: SERPINA5 antibody at 3μg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 46 kDa
Observed band size: 46 kDa

Immunohistochemistry analysis of human ovarian cancer using CSB-PA021061LA01HU at dilution of 1:100

Immunofluorescent analysis of HepG2 cells using CSB-PA021061LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) SERPINA5 Polyclonal antibody
Uniprot No.：

P05154
基因名：

SERPINA5
別名：

Acrosomal serine protease inhibitor antibody; IPSP antibody; IPSP_HUMAN antibody; PAI 3 antibody; PAI-3 antibody; PAI3 antibody; PCI antibody; PCI-B antibody; PLANH 3 antibody; PLANH3 antibody; Plasma serine protease inhibitor antibody; Plasminogen activator inhibitor 3 antibody; Plasminogen activator inhibitor III antibody; PROCI antibody; Protein C inhibitor antibody; Serpin A5 antibody; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 5 antibody; Serpin peptidase inhibitor clade A member 5 antibody; Serpina5 antibody
宿主：

Rabbit
反應種屬：

Human, Mouse, Rat
免疫原：

Recombinant Human Plasma serine protease inhibitor protein (157-367AA)
免疫原種屬：

Homo sapiens (Human)

標記方式：

Non-conjugated

本頁面中的產(chǎn)品，SERPINA5 Antibody (CSB-PA021061LA01HU)，的標記方式是Non-conjugated。對于SERPINA5 Antibody，我們還提供其他標記。見下表：

標記方式	貨號	產(chǎn)品名稱	應用
HRP	CSB-PA021061LB01HU	SERPINA5 Antibody, HRP conjugated	ELISA
FITC	CSB-PA021061LC01HU	SERPINA5 Antibody, FITC conjugated
Biotin	CSB-PA021061LD01HU	SERPINA5 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
應用范圍：

ELISA, WB, IHC, IF

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:5000
IHC	1:20-1:200
IF	1:50-1:200

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
Immunofluorescence (IF) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Heparin-dependent serine protease inhibitor acting in body fluids and secretions. Inactivates serine proteases by binding irreversibly to their serine activation site. Involved in the regulation of intravascular and extravascular proteolytic activities. Plays hemostatic roles in the blood plasma. Acts as a procoagulant and proinflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin complex. Acts as an anticoagulant factor by inhibiting blood coagulation factors like prothrombin, factor XI, factor Xa, plasma kallikrein and fibrinolytic enzymes such as tissue- and urinary-type plasminogen activators. In seminal plasma, inactivates several serine proteases implicated in the reproductive system. Inhibits the serpin acrosin; indirectly protects component of the male genital tract from being degraded by excessive released acrosin. Inhibits tissue- and urinary-type plasminogen activator, prostate-specific antigen and kallikrein activities; has a control on the sperm motility and fertilization. Inhibits the activated protein C-catalyzed degradation of SEMG1 and SEMG2; regulates the degradation of semenogelin during the process of transfer of spermatozoa from the male reproductive tract into the female tract. In urine, inhibits urinary-type plasminogen activator and kallikrein activities. Inactivates membrane-anchored serine proteases activities such as MPRSS7 and TMPRSS11E. Inhibits urinary-type plasminogen activator-dependent tumor cell invasion and metastasis. May also play a non-inhibitory role in seminal plasma and urine as a hydrophobic hormone carrier by its binding to retinoic acid.
基因功能參考文獻：
1. the snp rs1955656 in the SERPINA5 were associated with the development of severe acute kidney injury (KDIGO stage 2-3) in critically ill patients with septic shock PMID: 28270177
2. Data show that the methylation degree of five CpG sites significantly correlated with lower SERPINA5 expression levels. PMID: 29187436
3. We confirmed associations with papillary thyroid cancer and SNPs in FOXE1/HEMGN, SERPINA5 (rs2069974), FTO (rs8047395), EVPL (rs2071194), TICAM1 (rs8120) and SCARB1 (rs11057820) genes. We found associations with SNPs in FOXE1, SERPINA5, FTO, TICAM1 and HSPA6 and and follicular thyroid cancer PMID: 27207655
4. host protein C inhibitor expressed in mouse has a role in inhibiting tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability PMID: 25887633
5. These findings highlight an important role of SERPINA5 in the regulation of migratory and metastatic potentials of HCC and suggest a potential application of SERPINA5 in cancer treatment. PMID: 24388360
6. These results suggest that HIV resistance in some exposed patients is the result of a balance between downregulation of serine proteinases and upregulation of their inhibitors. PMID: 24928035
7. A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation. PMID: 23670045
8. Decreased SERPINA5 expression due to DNA promoter methylation is associated with papillary thyroid carcinoma. PMID: 24222120
9. the SERPINA5 gene, which codes for the protein C inhibitor involved in many biological processes including inflammation, may be a new susceptibility locus for PTC. PMID: 23520464
10. One of the monomers, 52-kDa PCI, formed a stable complex with activated protein C, urokinase, plasma and tissue kallikrein, but the dimer species and 48-kDa PCI were inactive. PMID: 22206708
11. the effects of N-glycans and the NH-terminus on a PCI function PMID: 22205989
12. SerpinA5 expression is significantly reduced in advanced-stage serous borderline tumors and serous carcinomas. PMID: 21102419
13. This study was undertaken to further understand the structural micro-heterogeneity of PCI. Individuals of two different ethnicities possess a similar PCI pattern, verifying that the micro-heterogeneity is conserved among humans. PMID: 21056543
14. APC-PCI complex levels were higher in peripheral arterial disease patients than in controls, but did not predict the clinical outcome. PMID: 20409682
15. function for PCI in innate immunity PMID: 20019810
16. In men involved in total fertilization failure, a heterozygous adenosine/guanine (A/G) base combination in position 1389 (rs2069990) (exon 6) in the protein C inhibitor gene was significantly more common compared with controls (10.9% vs. 0). PMID: 19765701
17. PCI can up regulate TAFI activation by inhibiting the protein C activation. PCI may therefore be an important regulator in the balance between coagulation and fibrinolysis by differentially inhibiting the activation of TAFI and of protein C. PMID: 11686324
18. Role of each Asn-linked glycan in the anticoagulant activity of human protein C inhibitor. PMID: 11864713
19. Protein C inhibitor regulates the invasive potential of renal cell carcinoma by inhibiting urinary plasminogen activator secreted by these cells PMID: 14696115
20. PCI may be involved in regulating key serine proteases involved in metastatic prostate disease PMID: 15878512
21. exposure of oxidized PE and/or PS may be important for the local regulation of protein C inhibitor activity in vivo PMID: 17332248
22. anti-angiogenic activity of PCI was strong as cleaved antithrombin, and slightly stronger than that of plasminogen activator inhibitor-1 and pigment epithelium-derived factor PMID: 17450526
23. Patients with abdominal aortic aneurysm have increased thrombin generation reflected by an increase in the activated protein C-protein C inhibitor complex, which correlates with aneurysm size. PMID: 18184931
24. In human renal tissues, PCI and urinary plasminogen activator colocalized in the cytoplasm of renal proximal tubular epithelial cells PMID: 18193533
25. A crystallographic structure of the Michaelis complex of PCI, thrombin, and heparin to 1.6 A resolution, was determined. PMID: 18362344
26. The heparin binding site of protein C inhibitor is protease-dependent. PMID: 18974053
顯示更多

收起更多
亞細胞定位：

Secreted, extracellular space. Note=Localized on the plasma membrane overlying the acrosomal head of spermatozoa of ependymal spermatozoa and ejaculated sperm. Localized at the equatorial segment of acrosome-reacted spematozoa. Localized in alpha granules in resting platelets and on the external plasma membrane and within the surface-connected cannalicular system in activated platelets.
蛋白家族：

Serpin family
組織特異性：

Predominantly expressed in the epithelium of seminal vesicles. Expressed in the proximal tubular epithelium of the kidney. Expressed in the superficial and more differentiated epidermal keratinocytes of the skin. Expressed in megakaryocytes and platelets.
數(shù)據(jù)庫鏈接：

HGNC: 8723

OMIM: 601841

KEGG: hsa:5104

STRING: 9606.ENSP00000333203

UniGene: Hs.159628

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human